newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer

Facility is on track to be fully operational in 2024 HAMILTON, ON, May 2, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN), a clinical-stage oncology company focused on developing next-generation